Wilmington, NC8 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Wilmington, NC

Find 8 actively recruiting myalgic encephalomyelitis clinical trials in Wilmington, NC. Connect with local research sites and explore new treatment options.

8
Active Trials
8
Sponsors
3,066
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Wilmington

About Myalgic Encephalomyelitis Clinical Trials in Wilmington

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 8 myalgic encephalomyelitis clinical trials recruiting participants in Wilmington, NC. These studies are seeking a combined 3,066 participants. Research is being sponsored by NeuraLight, Children's Oncology Group, CLASSYS Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Wilmington — FAQ

Are there myalgic encephalomyelitis clinical trials in Wilmington?

Yes, there are 8 myalgic encephalomyelitis clinical trials currently recruiting in Wilmington, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wilmington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.

Are clinical trials in Wilmington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 8 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated September 3, 2026 from ClinicalTrials.gov